|
Anecdotal
Cases
Anecdotal Case 1
Report Date: 8/25/02
Patient: J.H , 48 years old, CFS since
1991
Clinic: Clymer Healing Research Center
5916 Clymer Road
Quakertown, PA 18951
Dr Poesnecker ND, DC
Product: NatCell® CF Support, 24-day protocol
Observed results for the starting dose and supporting
dose:
Immediate improvement in overall muscle weakness
Gradual improvement was noticed in the following
areas:
Observed results for the Maximum dose:
Improvements listed above processed
· During three out of the eight days,
she experienced anxiety and agitation throughout
the day.
· After completion of the 24-day cycle,
the improvements were maintained for 7-10 days,
with symptoms gradually returning to prior levels.
Observed results on maintenance program
(1 vial per week):
Anecdotal
Case 2
CF-Support
48 year old menopaused patient (by hysterectomy) 5
years ago following a fibroma. No other
antecedent requiring surgery. Two normal pregnancies
(23 and 28 years old). Suffered from slight
hypertension in 1992 following a job loss.
No medication was necessary. In 1999,
suffered from diffused muscular pains, insomnia, weight
loss and asthenia.
Diagnosis: fibromyalgia.
In 2000, constant fatigue and slight anaemia.
Diagnosis: chronic
fatigue.
She took iron supplements, hormonotherapy
and Paxil (for a 3 months period). In 2001,
hormonotherapy ceased. Fatigue and pain
persisted. This patient has a vegetarian
diet and exercises regularly. She has
a stressing job (accountant). In January
2002, slight improvement of the general health following
a treatment of adrenal extracts pills, anti-oxidants
and a PH adjustment.
In May 2002, introduction of CF-Support.
First week: no improvement.
2nd week: less pain,
improved sleep, energy level more stable.
3rd week: progression
of energy level.
Following the treatment, the energy
level of this patient has improved 60 to 70%.
Up to now, the energy level seems to remain stable.
Autumn could bring some changes.
<:::Back
| Table
of Contents | Next:::>
2003
Atrium Biotechnologies Inc. All Rights Reserved 4/19
©CF Support Scientific Review
|